Active Biotech's election committee appointed
17 November 2017 - 6:30PM
PRESS RELEASE
In accordance
with a decision made by the Annual General Meeting held on 15 June,
2017, the Election Committee shall comprise the representatives for
the three largest shareholders, as per end of September 2017, and
the Chairman of the Board.
For the 2018 Annual General
Meeting, the Election Committee shall propose Board members and a
Chairman of the Board, and fees to Board members and auditors. The
following individuals were appointed representatives for the
largest shareholders and, accordingly, are members of the Election
Committee:
Johnny Sommarlund, MGA
Holding
Tomas Billing, Nordstjernan
Per Colleen, Fjärde AP-fonden
Under the leadership of the
Chairman of the Board, Mats Arnhög, the Election Committee shall
prepare proposals to be presented to and decided upon at the Annual
General Meeting on May 17, 2018.
Lund, November 17, 2017
Active Biotech AB (publ)
Helén Tuvesson
President and CEO
Active Biotech AB (publ)
(NASDAQ Stockholm: ACTI) is a biotechnology company with focus on
neurodegenerative/inflammatory diseases and cancer. Laquinimod, an
orally administered small molecule with unique immunomodulatory
properties, is in Phase II development for the treatment of primary
progressive multiple sclerosis and Huntington's disease. ANYARA, an
immunological substance, has completed clinical Phase I-II/III
studies in patients with pancreatic, lung or renal cell cancer.
Furthermore, commercial activities are conducted for the
tasquinimod, paquinimod and SILC projects. Please visit
www.activebiotech.com for more information.
Active Biotech AB
(Corp. Reg. No. 556223-9227)
Box 724, SE-220 07 Lund, Sweden
Tel: +46 (0)46 19 20 00
This information was submitted for publication,
through the agency of the contact person set out above,
at 08.30 a.m. CET on November
17, 2017.
Active Biotech's election committee
appointed
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Active Biotech via Globenewswire
Actividentity Corp (MM) (NASDAQ:ACTI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Actividentity Corp (MM) (NASDAQ:ACTI)
Historical Stock Chart
From Apr 2023 to Apr 2024